Keybank National Association OH increased its position in shares of Baxter International Inc. (NYSE:BAX – Free Report) by 189.8% in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 97,791 shares of the medical instruments supplier’s stock after buying an additional 64,052 shares during the period. Keybank National Association OH’s holdings in Baxter International were worth $2,347,000 at the end of the most recent reporting period.
Several other institutional investors have also recently added to or reduced their stakes in the business. CX Institutional increased its stake in Baxter International by 2.3% in the third quarter. CX Institutional now owns 19,858 shares of the medical instruments supplier’s stock valued at $477,000 after purchasing an additional 448 shares in the last quarter. Baird Financial Group Inc. grew its stake in shares of Baxter International by 1.1% in the 2nd quarter. Baird Financial Group Inc. now owns 44,722 shares of the medical instruments supplier’s stock valued at $953,000 after buying an additional 476 shares during the period. North Dakota State Investment Board increased its position in Baxter International by 3.3% in the 3rd quarter. North Dakota State Investment Board now owns 15,735 shares of the medical instruments supplier’s stock valued at $378,000 after buying an additional 500 shares in the last quarter. CWA Asset Management Group LLC increased its position in Baxter International by 5.0% in the 3rd quarter. CWA Asset Management Group LLC now owns 12,617 shares of the medical instruments supplier’s stock valued at $303,000 after buying an additional 599 shares in the last quarter. Finally, Empirical Finance LLC increased its holdings in shares of Baxter International by 3.5% during the second quarter. Empirical Finance LLC now owns 18,170 shares of the medical instruments supplier’s stock valued at $387,000 after acquiring an additional 608 shares in the last quarter. 90.19% of the stock is owned by institutional investors and hedge funds.
Baxter International Trading Down 0.2%
Shares of Baxter International stock opened at $25.77 on Monday. The stock has a fifty day simple moving average of $24.54 and a 200 day simple moving average of $21.67. Baxter International Inc. has a 12-month low of $15.73 and a 12-month high of $30.00. The company has a market capitalization of $13.33 billion, a P/E ratio of -18.28, a price-to-earnings-growth ratio of 3.79 and a beta of 0.68. The company has a current ratio of 1.79, a quick ratio of 1.19 and a debt-to-equity ratio of 1.20.
Baxter International (NYSE:BAX – Get Free Report) last posted its quarterly earnings data on Thursday, October 29th. The medical instruments supplier reported $0.58 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.52 by $0.06. Baxter International had a negative net margin of 6.23% and a positive return on equity of 16.23%. The firm had revenue of $2.98 billion for the quarter, compared to the consensus estimate of $2.91 billion. During the same period in the previous year, the firm earned $0.69 EPS. The business’s revenue for the quarter was up 5.0% compared to the same quarter last year. On average, sell-side analysts anticipate that Baxter International Inc. will post 2.10 earnings per share for the current fiscal year.
Baxter International Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Monday, January 4th. Investors of record on Friday, November 27th will be given a dividend of $0.01 per share. This represents a $0.04 dividend on an annualized basis and a dividend yield of 0.2%. The ex-dividend date of this dividend is Friday, November 27th. Baxter International’s dividend payout ratio (DPR) is presently -2.84%.
Analyst Ratings Changes
A number of equities analysts have recently weighed in on BAX shares. TD Cowen upped their target price on Baxter International from $20.00 to $24.00 and gave the stock a “hold” rating in a research report on Monday, July 27th. Jefferies Financial Group restated a “hold” rating and set a $25.00 price target on shares of Baxter International in a research note on Thursday, October 29th. Zacks Research upgraded shares of Baxter International from a “strong sell” rating to a “hold” rating in a report on Tuesday, August 11th. Citigroup dropped their price objective on shares of Baxter International from $28.00 to $27.00 and set a “neutral” rating on the stock in a research note on Monday, October 5th. Finally, Stifel Nicolaus lifted their price objective on shares of Baxter International from $19.00 to $24.00 and gave the company a “hold” rating in a report on Tuesday, July 28th. One investment analyst has rated the stock with a Buy rating, ten have issued a Hold rating and three have assigned a Sell rating to the company. Based on data from MarketBeat, the stock has an average rating of “Reduce” and an average price target of $23.27.
View Our Latest Stock Report on Baxter International
Baxter International Profile
Baxter International is a global healthcare company that develops and supplies products used in hospitals, clinics and other care settings. Its offerings include intravenous solutions and administration sets, infusion pumps, medication-delivery systems, and products for surgical and hospital care. The company also provides patient-monitoring and connected-care technologies, including products associated with Hillrom, which Baxter acquired in 2021. Its products and services support healthcare professionals and patients in countries around the world.
Further Reading
- Five stocks we like better than Baxter International
- Beaming Up the Backlog: AeroVironment Lands $405M Laser Deal
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
Want to see what other hedge funds are holding BAX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Baxter International Inc. (NYSE:BAX – Free Report).
Receive News & Ratings for Baxter International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Baxter International and related companies with MarketBeat.com's FREE daily email newsletter.
